Catecholamines and Parkinson's disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview.

MLA

Nagatsu, Toshiharu. “Catecholamines and Parkinson’s Disease: Tyrosine Hydroxylase (TH) over Tetrahydrobiopterin (BH4) and GTP Cyclohydrolase I (GCH1) to Cytokines, Neuromelanin, and Gene Therapy: A Historical Overview.” Journal of Neural Transmission, vol. 131, no. 6, June 2024, pp. 617–30. EBSCOhost, https://doi.org/10.1007/s00702-023-02673-y.

APA

Nagatsu, T. (2024). Catecholamines and Parkinson’s disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview. Journal of Neural Transmission, 131(6), 617–630. https://doi.org/10.1007/s00702-023-02673-y

Chicago

Nagatsu, Toshiharu. 2024. “Catecholamines and Parkinson’s Disease: Tyrosine Hydroxylase (TH) over Tetrahydrobiopterin (BH4) and GTP Cyclohydrolase I (GCH1) to Cytokines, Neuromelanin, and Gene Therapy: A Historical Overview.” Journal of Neural Transmission 131 (6): 617–30. doi:10.1007/s00702-023-02673-y.